Using CRISPR Against Sickle Cell Disease
News Team member Ellie Purinton highlights a groundbreaking clinical trial using CRISPR gene editing as a potential cure for sickle cell disease. This innovative approach could revolutionize treatment for the majority of patients without access to traditional transplants.